Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...
Eli Lilly posts 54% revenue growth with Zepbound, Mounjaro, expanding pipeline, and rising market share. Learn why LLY stock ...
Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, driven not only by outstanding earnings and a notable margin increase, but ...
HealthDay on MSN
Eli Lilly Becomes First Trillion-Dollar Health Company
Key Takeaways Eli Lilly became the first healthcare company to hit a $1 trillion valuation (briefly on Nov. 21) Its diabetes ...
Morgan Stanley raised the firm’s price target on Eli Lilly (LLY) to $1,290 from $1,171 and keeps an Overweight rating on the ...
Just in time for the holiday season, Lilly unveiled its multi-pronged campaign to tie in Alzheimer’s awareness with cultural ...
Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, will ...
Indianapolis-based Eli Lilly is the first publicly traded U.S. healthcare company to reach market capitalization over $1 trillion, elevating the drugmaker to an exclusive list dominated by tech giants ...
The success of obesity drug Mounjaro turned Eli Lilly into the first $1 trillion drugmaker on Friday, while Danish rival Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback